AtaiBeckley (ATAI) Cash from Investing Activities (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Cash from Investing Activities of -$21.7 million in Q1 2026, down 96.6% quarter-over-quarter from -$11.0 million in Q1 2025, and down 96.6% on a YoY basis from -$636.0 million in Q1 2025.

AtaiBeckley (ATAI) Cash from Investing Activities (2020 - 2026) Analysis & Trends

AtaiBeckley has disclosed Cash from Investing Activities across 6 years of filings, most recently posting -$67.6 million for Q3 2025.

  • Cash from Investing Activities for Q3 2025 came in at -$67.6 million, down 371.95% year-over-year; the trailing twelve-month figure through Sep 2025 was -$62.2 million (down 220.15% YoY), and the FY2024 annual result was $59.2 million, up 211.03% from the prior year.
  • Cash from Investing Activities was -$21.7 million for Q1 2026 at AtaiBeckley, down from -$11.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$11.0 million in Q1 2025 to a low of -$21.7 million in Q1 2026.
  • The 5-year median for Cash from Investing Activities is -$823000.0 (2023), against an average of -$12.2 million.
  • Peak annual rise in Cash from Investing Activities reached 10857.33% in 2022, while the deepest fall reached 5670.92% in 2022.
  • AtaiBeckley's Cash from Investing Activities stood at -$48.6 million in 2021, then surged by 264.6% to $80.1 million in 2022, then slumped by 101.03% to -$823000.0 in 2023, then soared by 897.08% to $6.6 million in 2024, then plunged by 1129.77% to -$67.6 million in 2025.
  • The last three Cash from Investing Activities figures came in at -$67.6 million (Q3 2025), $9.8 million (Q2 2025), and -$11.0 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 AtaiBeckley 1.45 Bn 1.45 Bn - -21.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.65 Mn
Mar 31, 2026 -21.65 Mn
Sep 30, 2025 -67.55 Mn
Sep 30, 2025 -67.55 Mn
Jun 30, 2025 9.78 Mn
Jun 30, 2025 9.78 Mn
Mar 31, 2025 -11.01 Mn
Mar 31, 2025 -11.01 Mn
Mar 31, 2025 -11.01 Mn
Mar 31, 2025 -11.01 Mn
Dec 31, 2024 6.56 Mn
Dec 31, 2024 6.56 Mn
Sep 30, 2024 24.84 Mn
Sep 30, 2024 24.84 Mn
Jun 30, 2024 16.30 Mn
Jun 30, 2024 16.30 Mn
Mar 31, 2024 11.47 Mn
Mar 31, 2024 11.47 Mn
Dec 31, 2023 -823,000.00
Dec 31, 2023 -823,000.00